Panion & BF Biotech Inc
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment,… Read more
Panion & BF Biotech Inc (1760) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.039x
Based on the latest financial reports, Panion & BF Biotech Inc (1760) has a cash flow conversion efficiency ratio of 0.039x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$73.31 Million) by net assets (NT$1.90 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Panion & BF Biotech Inc - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Panion & BF Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Panion & BF Biotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Panion & BF Biotech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhongjie (Jiangsu) Technology Co.Ltd.
SHE:301072
|
N/A |
|
Namhae Chemical
KO:025860
|
0.220x |
|
Aimei Health Technology Co., Ltd Ordinary Share
NASDAQ:AFJK
|
-0.002x |
|
Allied Energy Inc
PINK:AGGI
|
-1.025x |
|
Sern Kou Resources Bhd
KLSE:7180
|
0.037x |
|
Zhejiang XinNong Chemical Co Ltd Class A
SHE:002942
|
0.047x |
|
Context Therapeutics Inc
NASDAQ:CNTX
|
-0.090x |
|
Changshu Tongrun Auto
SHG:603201
|
N/A |
Annual Cash Flow Conversion Efficiency for Panion & BF Biotech Inc (2009–2024)
The table below shows the annual cash flow conversion efficiency of Panion & BF Biotech Inc from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.92 Billion | NT$351.19 Million | 0.183x | +96.80% |
| 2023-12-31 | NT$1.91 Billion | NT$177.42 Million | 0.093x | -61.96% |
| 2022-12-31 | NT$2.01 Billion | NT$489.87 Million | 0.244x | +17.59% |
| 2021-12-31 | NT$1.93 Billion | NT$401.23 Million | 0.208x | +1868.28% |
| 2020-12-31 | NT$1.24 Billion | NT$-14.55 Million | -0.012x | -117.54% |
| 2019-12-31 | NT$1.36 Billion | NT$90.98 Million | 0.067x | +15.01% |
| 2018-12-31 | NT$1.35 Billion | NT$78.58 Million | 0.058x | -57.36% |
| 2017-12-31 | NT$835.25 Million | NT$113.97 Million | 0.136x | -37.91% |
| 2016-12-31 | NT$806.41 Million | NT$177.22 Million | 0.220x | +192.12% |
| 2015-12-31 | NT$775.03 Million | NT$58.30 Million | 0.075x | -29.74% |
| 2014-12-31 | NT$710.84 Million | NT$76.11 Million | 0.107x | -18.47% |
| 2013-12-31 | NT$656.55 Million | NT$86.22 Million | 0.131x | +825.27% |
| 2012-12-31 | NT$278.86 Million | NT$3.96 Million | 0.014x | +111.67% |
| 2011-12-31 | NT$296.98 Million | NT$-36.12 Million | -0.122x | -164.01% |
| 2010-12-31 | NT$301.62 Million | NT$-13.89 Million | -0.046x | -119.43% |
| 2009-12-31 | NT$324.61 Million | NT$76.98 Million | 0.237x | -- |